Editorials Oral bisphosphonates and oesophageal cancer BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4506 (Published 02 September 2010) Cite this as: BMJ 2010;341:c4506 Article Related content Metrics Responses Peer review Related articles Research Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort Published: 02 September 2010; BMJ 341 doi:10.1136/bmj.c4444 Student Case-control analysis within a UK primary care cohort: oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum Published: 16 November 2010; BMJ 341 doi:10.1136/sbmj.c6420 See more Choosing a core surgical training interview skills course BMJ August 08, 2017, 358 j3779; DOI: https://doi.org/10.1136/bmj.j3779 Royal College of Surgeons launches postgraduate surgical certificate BMJ May 31, 2017, 357 j2665; DOI: https://doi.org/10.1136/bmj.j2665 How to write an operation note BMJ January 25, 2017, 356 j355; DOI: https://doi.org/10.1136/bmj.j355 Constitutional symptoms in a young person BMJ December 07, 2016, 355 i5781; DOI: https://doi.org/10.1136/bmj.i5781 Return of the “firm” gets cautious welcome BMJ December 06, 2016, 355 i6554; DOI: https://doi.org/10.1136/bmj.i6554 Cited by... Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysisAbstract Fulltext PDF Mechanisms of bone anabolism regulated by statinsAbstract Fulltext PDF Case-control analysis within a UK primary care cohort: oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectumAbstract Fulltext PDF
